| Literature DB >> 31229516 |
Michael D Gross1, Mark N Alshak2, Jonathan E Shoag1, Aaron A Laviana3, Michael A Gorin4, Art Sedrakyan5, Jim C Hu6.
Abstract
Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.Entities:
Year: 2019 PMID: 31229516 DOI: 10.1016/j.urology.2019.06.011
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649